BPG is committed to discovery and dissemination of knowledge
Citation
Han F, Wang XH, Xu CZ. Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(7): 3308-3320 [PMID: 39072161 DOI: 10.4251/wjgo.v16.i7.3308] (0) (0)
Please LOGIN to submit a new comment.
Write to the Help Desk